A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies' access efforts are

Contributed by: GlobeNewswire

Tags

Access

More Like This

2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries

New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance

Air pollution over Shanghai illustrating the climate health crisis. (Photo: Business Wire)

Global Healthcare Leaders Advance Sector Decarbonisation Ahead of COP28

Business Wire logo

AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030

PR Newswire associated0

Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets

PR Newswire associated0

New Veeva Pulse Findings Show Connected Engagement Creates an Advantage as HCP Access Drops

GlobeNewswire associated0

UK falls to third place in global Health Inclusivity Index

PR Newswire associated0

Portuguese Faculty of Pharmacy launches 2nd edition of International Market Access postgraduate course